Clinical antiangiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer

OBJECTIVE: To assess the safety and clinical antiangiogenic effect of recombinant adenovirus-p53 (rAd-p53) combined with hyperthermia plus or not plus radiotherapy in advanced cancer. METHODS: Expression of Vascular epithelial growth factor (VEGF) after intratumoral injection of rAd-p53 was assayed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Li, Xiaofan, Xiao, Shaowen, Li, Yongheng, Zhang, Shanwen
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2013
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3872542/
https://ncbi.nlm.nih.gov/pubmed/24385704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2013.12.05
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge